SMS Antikörper (AA 245-350)

Produktnummer ABIN1387423

Produktdetails anti-SMS Antikörper

Target: SMS (Spermine Synthase, SMS (SMS))

Bindungsspezifität: AA 245-350

Reaktivität: Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SMS Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Maus

Homologie: Human,Rat,Dog,Cow,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Spermine synthase

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu SMS

Target: SMS (Spermine Synthase, SMS (SMS))

Andere Bezeichnung: Spermine Synthase (SMS Produkte)

Synonyme: MRSR antikoerper, SPMSY antikoerper, SRS antikoerper, SpS antikoerper, AI427066 antikoerper, Gy antikoerper, SpmST antikoerper, gyro antikoerper, spermine synthase antikoerper, SMS antikoerper, Sms antikoerper

Hintergrund:

Synonyms: MRSR, SMS, Snyder Robinson X linked mental retardation syndrome, Spermidine aminopropyltransferase, Spermine synthase, SPMSY, SpS, SPSY_HUMAN, SRS.

Background: Spermine synthase catalyzes the production of spermine from spermidine. Spermine, a polyamine ubiquitously present in most organisms, is essential for normal cell growth and differentiation. Because absence of spermine increases sensitivity of cells to anti-tumor agents, spermine synthase (and other polyamine biosynthesis) is an attractive target for anti-neoplastic therapy.